MIRA INFORM REPORT

 

 

Report Date :

02.06.2014

 

IDENTIFICATION DETAILS

 

Name :

SYMED LABS LIMITED

 

 

Formerly Known As :

SYMED LABS PRIVATE LIMITED

 

 

Registered Office :

8-3-166/6 and 7, 2nd Floor, Sree Arcade, Erragadda, Hyderabad – 500 018, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

17.08.1998

 

 

Com. Reg. No.:

01-029961

 

 

Capital Investment / Paid-up Capital :

Rs.9.301 millions

 

 

CIN No.:

[Company Identification No.]

U24231AP1998PLC029961

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS03532E

 

 

PAN No.:

[Permanent Account No.]

AADCS5186M

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs and Intermediates, Active Pharmaceutical Ingredient and also engaged into windmill-based power generation.

 

 

No. of Employees :

Information declined by the Management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (48)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 4474000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

The rating reflect Symed’s established position in the active pharmaceutical ingredients (API) manufacturing segment, supported by healthy operating efficiencies, and adequate financial position of the company.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

US investment bank Goldman Sachs  has upgraded its outlook on Indian markets as it expects positive impact of the election cycle.

 

India’s economy may grow 4.7 % in the current financial year, lower than the official estimate of 4.9 %, Fitch Rating said. The global rating agency expects the economy to pick up in the next two financial years.

 

Global ratings agency Standard & Poor said increasing focus by India Inc on lowering debt is likely to improve their credit profiles.

 

Singapore (1.1 million Indian tourists in 2012), Thailand (one million), the United Arab Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred holidays hotspots for Indians. The total figure is expected to increase to 1.93 million by 2017, according to the latest Eurmonitor international report.

 

There is a $29.34 bn outward foreign direct investment by domestic companies between April and January of 2013/14 which has seen some signs of recovery according to a Care Ratings report.

 

There are 264 number of new companies being set up every day on average during 2014. Most of them are registered in Mumbai. India had 1.38 million registered companies at the end of January, 2014.

 

Twitter like messaging service Weibo Corporation has filed to raise $ 500 million via a US initial public offering. Alibaba, which owns a stake in Weibo is expected to raise about $ 15 billion New York this year in the highest profile Internet IPO since Facebook’s in 2012.

 

Bharti Airtel has raised Rs.2,453.2 crore (350 million Swiss Francs) by selling six-year bonds at a coupon rate of three per cent and maturing in 2020. This is the largest ever bond offering by an Indian company in Swiss Francs. Bharat Petroleum Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98 % coupon rate in February.

 

Indian Oil Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex at its almost complete Paradip refinery in Odhisha in three to four years. The company board is set to consider the setting up of a 700000 tonne per annum polypropylene plant at an estimated cost at Rs.3150 crore.

 

Global chief information officers at gathering in Bangalore in April to meet Indian startups at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in the making.


 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Rating: BBB+

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

September 11, 2013

 

 

Rating Agency Name

CRISIL

Rating

Short Term Rating: A2

Rating Explanation

Strong degree of safety and low credit risk.

Date

September 11, 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION DECLINED

 

Management non-cooperative

 

(Tel. No.: 91-40-23708103)

 

LOCATIONS

 

Registered Office :

8-3-166/6 and 7, 2nd Floor, Sree Arcade, Erragadda, Hyderabad – 500 018, Andhra Pradesh, India

Tel. No.:

91-40-23708103/ 23812650/ 23704923/ 24

Fax No.:

91-40-23708103

E-Mail :

sambhram.p@heterodrugs.com

info@symedlabs.com

dmohanrao@symedlabsltd.com

ramu@heterdrugs.com

vasucs@heterodrugs.com

accounts@symedlabs.com

ekta.b@heterodrugs.com

kvvrao@symedlabs.com

Website :

http://www.symedlabs.com

 

 

Factory 1 :

Domadugu Village, Jinnaram Mandal, Medak District – 502 313, Andhra Pradesh, India

 

 

Factory 2 :

Plot No.25/B, Phase – III, IDA, Jeedimetla, Hyderabad – 500 055, Andhra Pradesh, India

 

 

Factory 3 :

Plot No.19 and 20, Phase – I, IDA, Jeedimetla, Hyderabad - 500 055, Andhra Pradesh, India

 

 

Wind Power Plant :

SF Nos.65, 91, 1102/2, Taluka: Bhachu, Kutch District, Gujarat, India

 

 

Branch Office 1 :

214, Somdutt Chamber - 2, Bhikaji Cama Place, New Delhi – 110 066, India

 

 

Branch Office 2 :

No.30/6, Cathedral Garden Lane, Kodambakkam High Road, Nungambakkam, Chennai – 600 034, Tamilnadu, India

 

 

DIRECTORS

 

AS ON 26.09.2013

 

Name :

Dr. Mohana Rao Dodda

Designation :

Managing Director

Address :

H. No.21, Madhuranagar Colony, S.R. Nagar, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

11.04.1958

Qualification :

M Sc., Ph. D.

Experience :

30 Years

Date of Appointment :

01.04.2012

DIN No.:

00126836

PAN No.:

ADSPD2583L

 

 

Name :

Dr. Bandi Partha Saradhi Reddy

Designation :

Director

Address :

Plot No.389, Road No.22/B, Jubilee Hills, Check Post, Madhapur Road, Hyderabad – 500 033, Andhra Pradesh, India

Date of Birth/Age :

06.03.1954

Date of Appointment :

31.03.2009

DIN No.:

00015899

PAN No.:

AABPD7067K

 

 

Name :

Mr. Srinivasa Reddy Male

Designation :

Director

Address :

Plot No.933, Vivekananda Nagar, Kukatpally, Hyderabad – 500 072, Andhra Pradesh, India

Date of Birth/Age :

02.02.1973

Qualification :

MBA

Date of Appointment :

06.09.2007

PAN No.:

AARPM1219Q

DIN No.:

00016085

 

 

Name :

Mr. Vamsikrishna Bandi

Designation :

Director

Address :

Plot No.389, Road No.22/B, Jubilee Hills, Check Post, Madhapur Road, Hyderabad – 500 033, Andhra Pradesh, India

Date of Birth/Age :

31.07.1983

Qualification :

M.S. Chemical

Date of Appointment :

01.04.2012

DIN No.:

01014619

PAN No.:

AIPPB1881R

 

 

Name :

Mr. Nandachary Mudumbi

Designation :

Whole-time Director

Address :

8-5-222/ B/26(401), E 10,11 Vengal Rao Nagar, Erragadda, Hyderabad – 500 038, Andhra Pradesh, India 

Date of Birth/Age :

23.02.1956

Qualification :

EE Chemical

Date of Appointment :

24.09.2012

DIN No.:

02714333

 

 

KEY EXECUTIVES

 

Name :

K.V.V. Rao

Designation :

Marketing Manager

Email ID:

kwrao@symedlabs.com

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 26.09.2013

 

Names of Shareholders

 

 

No. of Shares

Mohan Rao Dodda

 

245000

A.V. Narasa Reddy

 

100

D. Vandana

 

110000

D. Spandana

 

110000

Bandis Investments Private Limited, India

 

180000

Bandi Partha Saradhi Reddy

 

120000

M. Krishna Sindhuri

 

92500

B. Kalavathi

 

40000

Vamsikrishna Bandi

 

32500

Total

 

930100

 

AS ON 26.09.2013

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Bodies corporate

 

19.35

Directors or relatives of directors

 

80.64

Other top fifty shareholders

 

0.01

Total

 

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs and Intermediates, Active Pharmaceutical Ingredient and also engaged into windmill-based power generation.

 

 

Products :

ITC Code

 

Product Descriptions

84799040

Bulk Drugs

 

PRODUCTION STATUS (AS ON 31.03.2011):

 

Class of Goods Manufacture

 

Bulk Drugs

Installed Capacity

2000 MT’S

Actual Production

1699

 

GENERAL INFORMATION

 

No. of Employees :

Information declined by the Management.

 

 

Bankers :

  • State Bank of Mysore, RASMECCCC, 2-1-340/16, First Floor, Sai Tara Towers, Nallakunta Chowrasta, Hyderabad – 500 044, Andhra Pradesh, India
  • Andhra Bank, Specialized Corporate Finance Branch, 3rd Floor, Padmaja Land Mark, Somajiguda, Hyderabad – 500 082, Andhra Pradesh, India

 

 

Facilities :

Secured Loans

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

(Term loan fixed assets, corporate loan fixed assets and present and future)

(Term loan repayable in 33 monthly installments and corporate loan in four quarterly installments)

162.916

237.917

SHORT-TERM BORROWINGS

 

 

Loans repayable on demand from banks

(Hypothecation of stocks, stores and spares and book debts not older than 120 days and Second charge on current assets of the company and also guaranteed by Managing Director in his personal capacity)

368.013

371.188

Total

530.929

609.105

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

M.V. Narayana Reddy and Company

Chartered Accountants

Address :

504, Vijayasree Apartments, Behind Chermas, Ameerpet, Hyderabad – 500 073 Andhra Pradesh, India

Income-tax PAN of auditor or auditor's firm :

AADFM4830F

 

 

Associates :

  • Hetero Drugs Limited, India (CIN No.: U24230AP1993PLC015582)
  • Hetero Labs Limited, India (CIN No.: U24110AP1989PLC009723)
  • Cirex Pharmaceuticals Limited, India (CIN No.: U24239AP1990PLC012119)
  • Hetero Singapore Pte Limited, Singapore
  • Invagen Pharmaceuticals Inc, United States
  • Hetero FZCO, United Arab Emirates
  • Sri Chenna Kesava Bio Energy Private Limited, India (CIN No.: U40108AP2011PTC077815)
  • Honour Lab Limited, India (CIN No.: U24233AP2011PLC077561)
  • Hetero USA Inc, United States
  • Honour Infra Estates Limited, India (CIN No.: U45400AP2012PLC083644)
  • Symed Chemicals Private Limited, India (CIN No.: U24110AP2008PTC058116)

 

 

Subsidiary Companies :

  • Chemi Pack (India) Private Limited, India (CIN No.: U21023AP2007PTC054088)
  • MEDSY FZE, United Arab Emirates

 

 

CAPITAL STRUCTURE

 

AS ON 26.09.2013

 

Authorized Capital:

No. of Shares

Type

Value

Amount

2000000

Equity Shares

Rs.10/- each

Rs.20.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital:

No. of Shares

Type

Value

Amount

930100

Equity Shares

Rs.10/- each

Rs.9.301 millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

9.301

9.301

9.301

(b) Reserves & Surplus

1109.299

979.582

859.672

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1118.600

988.883

868.973

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

162.916

237.917

0.110

(b) Deferred tax liabilities (Net)

185.647

121.347

61.610

(c) Other long term liabilities

0.000

0.000

0.000

(d) Long-term provisions

3.570

2.767

0.000

Total Non-current Liabilities (3)

352.133

362.031

61.720

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

368.013

451.188

187.654

(b) Trade payables

227.875

214.330

119.944

(c) Other current liabilities

198.075

282.517

71.776

(d) Short-term provisions

66.144

65.543

87.241

Total Current Liabilities (4)

860.107

1013.578

466.615

 

 

 

 

TOTAL

2330.840

2364.492

1397.308

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1000.201

1080.182

602.528

(ii) Intangible Assets

0.305

0.029

0.000

(iii) Capital work-in-progress

2.287

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

29.123

28.675

32.643

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

183.932

145.088

82.497

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

1215.848

1253.974

717.668

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

357.108

331.816

269.936

(c) Trade receivables

624.645

507.695

352.470

(d) Cash and cash equivalents

58.101

193.487

7.390

(e) Short-term loans and advances

11.039

10.810

6.694

(f) Other current assets

64.099

66.710

43.150

Total Current Assets

1114.992

1110.518

679.640

 

 

 

 

TOTAL

2330.840

2364.492

1397.308

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Revenue from operations

1708.211

1310.946

1118.628

 

 

Other Income

19.884

13.121

4.077

 

 

TOTAL                                     (A)

1728.095

1324.067

1122.705

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

892.265

721.594

598.936

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(30.296)

(13.173)

(18.923)

 

 

Employee benefit expense

105.919

87.524

73.340

 

 

Other expenses

360.797

229.142

192.513

 

 

TOTAL                                     (B)

1328.685

1025.087

845.866

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

399.410

298.980

276.839

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

91.816

33.191

21.703

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

307.594

265.789

255.136

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

57.189

32.642

24.082

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                (G)

250.405

233.147

231.054

 

 

 

 

 

Less

TAX                                                                  (H)

115.284

107.832

59.066

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

135.121

125.315

171.988

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Export

532.605

417.620

250.333

 

TOTAL EARNINGS

532.605

417.620

250.333

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

294.775

226.467

368.759

 

 

Capital Goods

12.715

4.937

8.415

 

TOTAL IMPORTS

307.490

231.404

377.174

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

145.00

135.00

184.91

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

7.82

9.46

15.32

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

14.66

17.78

20.66

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

10.89

9.98

16.93

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.22

0.24

0.27

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.47

0.70

0.22

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.30

1.10

1.46

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns.)

(INR in Mlns.)

(INR in Mlns.)

Share Capital

9.301

9.301

9.301

Reserves & Surplus

859.672

979.582

1109.299

Share Application money pending allotment

0.000

0.000

0.000

Net worth

868.973

988.883

1118.600

 

 

 

 

Long-term borrowings

0.110

237.917

162.916

Short term borrowings

187.654

451.188

368.013

Total borrowings

187.764

689.105

530.929

Debt/Equity ratio

0.216

0.697

0.475

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Revenue from operations

1,118.628

1,310.946

1,708.211

 

 

17.192

30.304

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Revenue from operations

1,118.628

1,310.946

1,708.211

Profit

171.988

125.315

135.121

 

15.37%

9.56%

7.91%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

PAN of Proprietor/Partner/Director, if available

Yes

32]

Date of Birth of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

Unsecured Loans

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG-TERM BORROWINGS

 

 

Loans and advances from directors

0.000

80.000

Total

0.000

80.000

 

 

Bankers Charges Report as per Registry

 

Corporate identity number (CIN) or foreign company

registration number of the company

U24231AP1998PLC029961

Name of the company

SYMED LABS LIMITED

Address of the registered office or of the principal place of  business in India of the company

8-3-166/6 and 7, 2nd Floor, Sree Arcade, Erragadda, Hyderabad – 500 018, Andhra Pradesh, India

E-Mail : sambhram.p@heterodrugs.com

This form is for

Creation of charge

Type of charge

Others (Corporate Guarantee)

Particular of charge holder

State Bank of Mysore, RASMECCCC, 2-1-340/16, First Floor, Sai Tara Towers, Nallakunta Chowrasta, Hyderabad – 500 044, Andhra Pradesh, India

E-Mail: rasmeccchyd@sbm.co.in

Nature of instrument creating charge

1. Letter of Arrangement

2. Guarantee Agreement

Date of instrument Creating the charge

13.06.2013

Amount secured by the charge

Rs.79.000 millions

Brief of the principal terms and conditions and extent and operation of the charge

Rate of Interest:

15.90% p.a. on Working Capital

 

Terms of Repayment:

Working Capital: Repayable on demand.

 

Margin:

For Cash Credit: 25% on stock and 40% on receivables/Book Debts

 

For ILCS & FLCS: 15% by way of deposit with Branch.

 

For Bank Guarantee Limit: 15% by way of deposit with Branch.

 

Extent and Operation of the charge:

Corporate Guarantee given for and on behalf of Chemi Pack (India) Private Limited in respect of renewal and enhancement of credit facilities of Rs.79.000 millions.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Corporate Guarantee given for and on  behalf of Chemi Pack (India) Private Limited in respect of renewal and enhancement of credit facilities of Rs.79.000 millions.

 

 

REVIEW OF THE BUSINESS OPERATIONS AND FUTURE PROSPECTS

 

Profitability of the company adversely affected by steep increase in cost of power and finance charges. During the year cost of power increased from 24.457 millions to 34.526 millions, cost of generator maintenance increased to 34.245 millions from 12.768 millions in the previous year and finance charges have also increased from 33.200 millions to 918 Lakhs.

 

During the year, the company achieved net revenues of Rs.1708.211 millions (including Rs.50.939 millions from Wind Power Division) as against Rs.1310.946 millions (Including Rs.0.492 million from Wind Power Division) in the previous year, thereby registering a growth of 30% over previous year. Similarly the profit before tax during the year is Rs.250.405 millions as against Rs.233.147 millions in the Previous year. Profitability of the company adversely affected by steep increase in cost of power and finance charges. During the year cost of power increased from 24.457 millions to 34.526 millions, cost of generator maintenance increased to 34.245 millions from 12.768 millions in the previous year and finance charges have also increased from 33.200 millions to 91.800 millions.

 

The directors are confident of achieving better results in the years to come.

 

 

FIXED ASSETS:

Tangible Assets

·         Land

·         Buildings

·         Plant and Machinery

·         Furniture and Fixtures

·         Computers

·         Vehicles

·         Office Equipment

Intangible Assets

·         Computer Software

·         Copyrights, patents and other operating rights

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.59.03

UK Pound

1

Rs.98.91

Euro

1

Rs.80.34    

 

 

INFORMATION DETAILS

 

Information Gathered by :

HTL

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

SMN

 

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

48

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.